Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Clin Chim Acta. 2017 Sep;472:112-117. doi: 10.1016/j.cca.2017.07.029. Epub 2017 Jul 31.
Synaptic vesicle 2 C (SV2C) is a novel isoform belonging to the synaptic vesicle 2 (SV2) protein superfamily; a family of proteins known to have roles in vesicle trafficking, exocytosis and neurotransmission. In humans, SV2C is expressed in evolutionarily older brain regions, and is a known receptor for botulinum neurotoxin/A (BoNT/A), controlling glucose-evoked granule recruitment and regulating dopamine release, thus serving as a potential target molecule in the treatment of psychosis. In addition, recent researches have shown that SV2C regulates hypertension and accelerates venous thromboembolism (VTE) and coagulation pathways and may play roles in several non-nervous system diseases. In terms of regulation, SV2C is positively regulated by both alendronate and statins. As SV2C may provide a potential novel therapeutic target for psychosis and other diseases, this article reviews the progress made thus far in understanding the structure, distribution, function and regulation of SV2C.
突触小泡蛋白 2C(SV2C)是突触小泡 2(SV2)蛋白超家族的一种新型同工型,该蛋白家族在囊泡运输、胞吐和神经递质传递中起作用。在人类中,SV2C 在进化上较老的脑区表达,是已知的肉毒杆菌神经毒素/A(BoNT/A)的受体,控制葡萄糖诱导的颗粒募集并调节多巴胺释放,因此作为治疗精神病的潜在靶分子。此外,最近的研究表明,SV2C 调节高血压并加速静脉血栓栓塞(VTE)和凝血途径,并且可能在几种非神经系统疾病中发挥作用。在调节方面,SV2C 受阿伦膦酸盐和他汀类药物的正调节。由于 SV2C 可能为精神病和其他疾病提供潜在的新型治疗靶标,因此本文综述了迄今为止在理解 SV2C 的结构、分布、功能和调节方面取得的进展。